Response to the letter to the editor submitted by Jaiswal A et al. (2020) regarding 'efficacy and safety of saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta-analysis' (Dutta et al.). Issue 6 (November 2020) - D, Dutta; S, Bhattacharya; V, Surana; S, Aggarwal; R, Singla; D, Khandelwal; M, Sharma